Corbus Pharmaceuticals Holdings, Inc. Property, Plant and Equipment
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Property, Plant and Equipment of $71.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Net $71.00K.
- 2026-03-31: Property, Plant and Equipment, Net $116.00K.
- 2025-12-31: Property, Plant and Equipment, Net $159.00K.
- 2025-09-30: Property, Plant and Equipment, Net $201.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $71.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $116.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $159.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $251.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $304.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $385.00K 10-K · filed 2026-03-09 | |
| 2024-09-30 | $519.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $671.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $821.53K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $973.00K 10-K · filed 2025-03-11 | $973.21K 10-K · filed 2024-03-12 |
| 2023-09-30 | $1.12M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.27M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.43M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.61M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.80M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.99M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.21M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.39M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $2.65M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.52M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.79M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $4.07M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $4.40M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.55M 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $4.85M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.08M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $4.89M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.91M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.69M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.71M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $2.70M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.67M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.59M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.43M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $337.30K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $418.51K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $409.79K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $435.25K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $345.43K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $291.17K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $296.53K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $124.14K 10-K · filed 2017-03-08 | |
| 2015-09-30 | $48.84K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $58.73K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $50.40K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $54.04K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $54.04K 10-Q · filed 2015-11-10 | $59.41K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |